Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 24

Sort by

Sort Order Select

Journal Articles

Global Prospective Cohort Study of Factors Associated with Venous Thromboembolism in Patients with Lung Cancer Receiving Cancer Therapy

Nicole M. Kuderer, MD, Marek S. Poniewierski, MD MS, MS, Eva Culakova, PhD MS, Gary H. Lyman, MD MPH, Alok A. Khorana, MD, Ingrid Pabinger, Prof, Giancarlo Agnelli, MD, Howard A. Liebman, MA, MD, Eric Vicaut, MD, Guy Meyer, MD, Frances A. Shepherd, MD FRCPC

Blood (2016) 128 (22): 3590.

https://doi.org/10.1182/blood.V128.22.3590.3590

Published: 2016

Journal Articles

Morbidity, Mortality and Costs Associated with Venous Thromboembolism in Hospitalized Patients with Cancer

Gary H. Lyman, MD MPH, Eva Culakova, PhD MS, Marek S. Poniewierski, MD MS, MS, Nicole M. Kuderer, MD

Blood (2016) 128 (22): 4751.

https://doi.org/10.1182/blood.V128.22.4751.4751

Published: 2016

Journal Articles

Risk Factors, Mortality, and Costs of Adults with Acute Myeloid Leukemia (AML) Admitted to the Intensive Care Unit (ICU): A Longitudinal Cohort Study

Anna B. Halpern, MD, Eva Culakova, PhD MS, Roland B. Walter, MD PhD MS, Gary H. Lyman, MD MPH

Blood (2015) 126 (23): 531.

https://doi.org/10.1182/blood.V126.23.531.531

Published: 2015

Journal Articles

Cost of Hospitalization in Patients with Cancer and Febrile Neutropenia and Impact of Comorbid Conditions

Gary H. Lyman, MD MPH, Marek S. Poniewierski, MD MS, Jeffrey Crawford, MD, David C. Dale, MD, Eva Culakova, PhD MS

Blood (2015) 126 (23): 2089.

https://doi.org/10.1182/blood.V126.23.2089.2089

Published: 2015

Journal Articles

Impact of Comorbidities on Length of Stay and Mortality in Hospitalized Patients with Cancer and Febrile Neutropenia

Eva Culakova, PhD MS, Marek S. Poniewierski, MD MS, Jeffrey Crawford, MD, David C. Dale, MD, Gary H. Lyman, MD MPH

Blood (2014) 124 (21): 2601.

https://doi.org/10.1182/blood.V124.21.2601.2601

Published: 2014

Journal Articles

Morbidity, Mortality and Costs Associated with Venous Thromboembolism in Hospitalized Patients with Cancer

Gary H. Lyman, MD MPH, Eva Culakova, PhD MS, Marek S. Poniewierski, MD MS, Nicole M. Kuderer, MD

Blood (2014) 124 (21): 2613.

https://doi.org/10.1182/blood.V124.21.2613.2613

Published: 2014

Journal Articles

Risk Score For Venous Thromboembolism (VTE) In Ambulatory Patients: Impact Of Cancer Type and Risk Score On VTE Incidence, Early Mortality and Progression-Free Survival

Nicole M. Kuderer, MD, Alok A. Khorana, MD, Charles Francis, Eva Culakova, PhD, MS, Gary H. Lyman, M.D., M.P.H.

Blood (2013) 122 (21): 3597.

https://doi.org/10.1182/blood.V122.21.3597.3597

Published: 2013

Journal Articles

Personalizing Cancer Supportive Care: Predicting Neutropenic Complications in Patients Receiving Intermediate Risk Cancer Chemotherapy

Gary H. Lyman, MD, MPH, Eva Culakova, PhD, MS, Marek S. Poniewierski, MD, MS, Jeffrey Crawford, MD, David C. Dale, MD, Nicole M. Kuderer, MD

Blood (2011) 118 (21): 1022.

https://doi.org/10.1182/blood.V118.21.1022.1022

Published: 2011

Journal Articles

Overall Survival of Lymphoma Patients In Randomized Controlled Trials Comparing Primary G-CSF Chemotherapy Support to Control.

Gary H. Lyman, MD, MPH, Jeffrey Crawford, Eva Culakova, PhD, MS, Marek S. Poniewierski, MD, MS, Mingyan Huang, Nicole M. Kuderer, MD, David C. Dale, MD

Blood (2010) 116 (21): 1502.

https://doi.org/10.1182/blood.V116.21.1502.1502

Published: 2010

Journal Articles

Acute Myeloid Leukemia or Myelodysplastic Syndromes and All-Cause Mortality in Randomized Controlled Trials of Cancer Patients Receiving Chemotherapy with or without Granulocyte Colony-Stimulating Factor: A Systematic Review and Meta-Analysis.

Gary H. Lyman, MD, MPH, Jeffrey Crawford, MD, Eva Culakova, PhD, MS, Marek S. Poniewierski, MD, MS, Debra Wolff, MS, PCNP, Nicole M. Kuderer, MD, David C. Dale, MD

Blood (2009) 114 (22): 3100.

https://doi.org/10.1182/blood.V114.22.3100.3100

Published: 2009

Journal Articles

Final Risk Prediction Model for Neutropenic Complications in Patients Receiving Cancer Chemotherapy

Gary H. Lyman, MD, MPH, Jeffrey Crawford, MD, Nicole M. Kuderer, MD, Debra Wolff, MS, PCNP, Eva Culakova, PhD, MS, Marek S. Poniewierski, MD, MS, David C. Dale, MD

Blood (2008) 112 (11): 1312.

https://doi.org/10.1182/blood.V112.11.1312.1312

Published: 2008

Journal Articles

Venous Thromboembolism Risk Model Predicts Early Progression and Overall Mortality in Cancer Patients Receiving Chemotherapy

Nicole M. Kuderer, MD, Alok A. Khorana, MD, Charles W. Francis, MD, Eva Culakova, PhD, MS, Thomas L. Ortel, MD, PhD, Anna Falanga, MD, Gary H. Lyman, MD, MPH

Blood (2008) 112 (11): 172.

https://doi.org/10.1182/blood.V112.11.172.172

Published: 2008

Journal Articles

Standard Versus Dose-Intensified Chemotherapy with Granulocyte Colony-Stimulating Factor for Malignant Lymphoma: Evaluation of Risk for Acute Myeloid Leukemia or Myelodysplastic Syndrome

Gary H. Lyman, MD, MPH, David C. Dale, MD, Debra Wolff, MS, PCNP, Eva Culakova, PhD, MS, Nicole M. Kuderer, MD, Marek S. Poniewierski, MD, MS, Jeffrey Crawford, MD

Blood (2008) 112 (11): 2390.

https://doi.org/10.1182/blood.V112.11.2390.2390

Published: 2008

Journal Articles

A Conditional Risk Model for Chemotherapy-Induced Anemia (CIA) in Cancer Patients.

Gary H. Lyman, MD, MPH, FRCP, Jeffrey Crawford, MD, Nicole M. Kuderer, MD, Debra A. Wolff, PCNP, Eva Culakova, PhD, Marek S. Poniewierski, MD, MS, David C. Dale, MD

Blood (2007) 110 (11): 372.

https://doi.org/10.1182/blood.V110.11.372.372

Published: 2007

Journal Articles

Prospective Validation of a Predictive Model for Early Anemia in Patients Receiving Cancer Chemotherapy.

Gary H. Lyman, MD, MPH, FRCP, David C. Dale, MD, Nicole M. Kuderer, MD, Debra A. Wolff, MS, PCNP, Eva Culakova, PHD, Marek S. Poniewierski, MD, MS, Jeffrey Crawford, MD, for the ANC Study Group

Blood (2006) 108 (11): 460.

https://doi.org/10.1182/blood.V108.11.460.460

Published: 2006

Journal Articles

A Prospective Risk Model for Neutropenic Complications in Patients with Malignant Lymphoma.

Gary H. Lyman, MD, MPH, Jeffrey Crawford, MD, Debra Wolff, MS, PCNP, Eva Culakova, PhD, Marek S. Poniewierski, MD, MS, David C. Dale, MD

Blood (2005) 106 (11): 3328.

https://doi.org/10.1182/blood.V106.11.3328.3328

Published: 2005

Journal Articles

A Risk Model for Chemotherapy-Induced Anemia (CIA) in Cancer Patients.

Gary H. Lyman, MD, MPH, Brandon McMahon, MD, Nicole M. Kuderer, MD, Jeffrey Crawford, MD, Debra Wolff, MS, PCNP, Eva Culakova, PhD, Marek S. Poniewierski, MD, MS, David C. Dale, MD

Blood (2005) 106 (11): 754.

https://doi.org/10.1182/blood.V106.11.754.754

Published: 2005

Journal Articles

First Cycle Risk of Severe and Febrile Neutropenia in Cancer Patients Receiving Systemic Chemotherapy: Results from a Prospective Nationwide Study.

Jeffrey Crawford, MD, Debra A. Wolff, MS, PCNP, Eva Culakova, PhD, Marek S. Poniewierski, MD, MS, Caleb Selby, David C. Dale, MD, Gary H. Lyman, MD, MPH, for the ANC Study Group

Blood (2004) 104 (11): 2210.

https://doi.org/10.1182/blood.V104.11.2210.2210

Published: 2004

Journal Articles

Thromboembolism in Hospitalized Neutropenic Cancer Patients.

Alok A. Khorana, MD, Charles W. Francis, MD, Eva Culakova, PhD, Richard I. Fisher, MD, Nicole Kuderer, MD, Gary H. Lyman, MD

Blood (2004) 104 (11): 2199.

https://doi.org/10.1182/blood.V104.11.2199.2199

Published: 2004

Journal Articles

Predicting the Risk of Neutropenic Complications and Reduced Dose Intensity in Patients with Malignant Lymphoma: Results from a Prospective Study.

David C. Dale, MD, Jeffrey Crawford, MD, Debra A. Wolff, MS, PCNP, Marek S. Poniewierski, MD, MS, Eva Culakova, PHD, Gary H. Lyman, MD, MPH, for the ANC Study Group

Blood (2004) 104 (11): 4599.

https://doi.org/10.1182/blood.V104.11.4599.4599

Published: 2004

NARROW

Global Prospective Cohort Study of Factors Associated with Venous Thromboembolism in Patients with Lung Cancer Receiving Cancer Therapy

Morbidity, Mortality and Costs Associated with Venous Thromboembolism in Hospitalized Patients with Cancer

Risk Factors, Mortality, and Costs of Adults with Acute Myeloid Leukemia (AML) Admitted to the Intensive Care Unit (ICU): A Longitudinal Cohort Study

Cost of Hospitalization in Patients with Cancer and Febrile Neutropenia and Impact of Comorbid Conditions

Impact of Comorbidities on Length of Stay and Mortality in Hospitalized Patients with Cancer and Febrile Neutropenia

Morbidity, Mortality and Costs Associated with Venous Thromboembolism in Hospitalized Patients with Cancer

Risk Score For Venous Thromboembolism (VTE) In Ambulatory Patients: Impact Of Cancer Type and Risk Score On VTE Incidence, Early Mortality and Progression-Free Survival

Personalizing Cancer Supportive Care: Predicting Neutropenic Complications in Patients Receiving Intermediate Risk Cancer Chemotherapy

Overall Survival of Lymphoma Patients In Randomized Controlled Trials Comparing Primary G-CSF Chemotherapy Support to Control.

Acute Myeloid Leukemia or Myelodysplastic Syndromes and All-Cause Mortality in Randomized Controlled Trials of Cancer Patients Receiving Chemotherapy with or without Granulocyte Colony-Stimulating Factor: A Systematic Review and Meta-Analysis.

Final Risk Prediction Model for Neutropenic Complications in Patients Receiving Cancer Chemotherapy

Venous Thromboembolism Risk Model Predicts Early Progression and Overall Mortality in Cancer Patients Receiving Chemotherapy

Standard Versus Dose-Intensified Chemotherapy with Granulocyte Colony-Stimulating Factor for Malignant Lymphoma: Evaluation of Risk for Acute Myeloid Leukemia or Myelodysplastic Syndrome

A Conditional Risk Model for Chemotherapy-Induced Anemia (CIA) in Cancer Patients.

Prospective Validation of a Predictive Model for Early Anemia in Patients Receiving Cancer Chemotherapy.

A Prospective Risk Model for Neutropenic Complications in Patients with Malignant Lymphoma.

A Risk Model for Chemotherapy-Induced Anemia (CIA) in Cancer Patients.

First Cycle Risk of Severe and Febrile Neutropenia in Cancer Patients Receiving Systemic Chemotherapy: Results from a Prospective Nationwide Study.

Thromboembolism in Hospitalized Neutropenic Cancer Patients.

Predicting the Risk of Neutropenic Complications and Reduced Dose Intensity in Patients with Malignant Lymphoma: Results from a Prospective Study.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only